Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition (original) (raw)

• Ahn, N.G. et al. Multiple components in an epidermal growth factor–stimulated protein kinase cascade: in vitro activation of a myelin basic protein/microtubule-associated protein 2 kinase. J. Biol. Chem. 266, 4220–4227 (1991).
  CAS PubMed Google Scholar
• Zheng, C-F. & Guan, K. Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. J. Biol. Chem. 268, 11435–11439 (1993).
  CAS PubMed Google Scholar
• Dhanasekaran, N. & Reddy, P. Signaling by dual-specificity kinases. Oncogene 17, 1447–1455 (1998).
  Article CAS Google Scholar
• Kolch, W. Ras/Raf signaling and emerging pharmacotherapeutic targets. Expert Opin. Pharmacother. 3, 709–718 (2002).
  Article CAS Google Scholar
• Schaeffer, H.J. & Weber, M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435–2444 (1999).
  Article CAS Google Scholar
• Lewis, T.S., Shapiro P.S. & Ahn, N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49–139 (1998).
  Article CAS Google Scholar
• Alessi, D.R. et al. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74 Raf-1. EMBO J. 13, 1610–1619 (1994).
  Article CAS Google Scholar
• Herrera, R. & Sebolt-Leopold, J.S. Unravelling the complexities of the Raf/MAP kinase pathway for pharmacological intervention. Trends Mol. Med. 8, S27–S31 (2002).
  Article CAS Google Scholar
• Kyriakis, J.M. & Avruch, J. Mammalian mitogen-activated signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81, 807–869 (2002).
  Article Google Scholar
• Dudley, D.T., Pang, L., Decker, S.J., Bridges, A.J. & Saltiel, A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92, 7686–7689 (1995).
  Article CAS Google Scholar
• Sebolt-Leopold, J.S. et al. Blockade of the MAP kinase pathway suppresses growth of colon tumours in vivo. Nat. Med. 5, 810–816 (1999).
  Article CAS Google Scholar
• Delaney, A.M., Printen, J.A., Chen, H., Fauman, E.B. & Dudley, D.T. Identification of a novel mitogen-activated protein kinase kinase activation domain recognized by the inhibitor PD184352. Mol. Cell. Biol. 22, 7593–7602 (2002).
  Article CAS Google Scholar
• Dang, A., Frost, J.A. & Cobb, M.H. The MEK1 proline-rich insert is required for efficient activation of the mitogen-activated protein kinases ERK1 and ERK2 in mammalian cells. J. Biol. Chem. 273, 19909–19913 (1998).
  Article CAS Google Scholar
• Hanks, S.K. & Hunter, T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9, 576–596 (1995).
  Article CAS Google Scholar
• Zheng, J. et al. 2.2 Å refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MnATP and a peptide inhibitor. Acta Crystallogr. D 49, 362–365 (1993).
  Article CAS Google Scholar
• Hubbard, S.R. et al. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16, 5572–5581 (1997).
  Article CAS Google Scholar
• Janin, J. & Chothia, C. The structure of protein-protein recognition sites. J. Biol. Chem. 265, 16027–16030 (1990).
  CAS Google Scholar
• Mizuguchi, K., Deane, C.M., Blundell, T.L., Johnson, M.S. & Overington, J.P. JOY: protein sequence-structure representation and analysis. Bioinformatics 14, 617–623 (1998).
  Article CAS Google Scholar
• De Azevedo, W.F. et al. Structural basis for specificity and potency of a flavonoid inhibitor of human Cdk2, a cell cycle kinase. Proc. Natl. Acad. Sci. USA 93, 2735–2740 (1996).
  Article CAS Google Scholar
• Pargellis, C. et al. Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nat. Struct. Biol. 9, 268–272 (2002).
  Article CAS Google Scholar
• Schindler, T. et al. Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science 289, 1938–1942 (2000).
  Article CAS Google Scholar
• De Bondt, H. et al. Crystal structure of cyclin-dependent kinase 2. Nature 363, 595–602 (1993).
  Article CAS Google Scholar
• Xu, W. et al. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595–602 (1997).
  Article CAS Google Scholar
• Sicheri, F. et al. Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602–609 (1997).
  Article CAS Google Scholar
• Parang, K. & Cole, P.A. Designing bisubstrate analog inhibitors for protein kinases. Pharmacol. Ther. 93, 145–157 (2002).
  Article CAS Google Scholar
• Manning, G. et al. The protein kinase complement of the human genome. Science 298, 1912–1934 (2002).
  Article CAS Google Scholar
• Davies, S.P., Reddy, H., Caivano, M. & Cohen, P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351, 95–105 (2000).
  Article CAS Google Scholar
• Mody, N., Leitch, J., Armstrong, C., Dixon, J. & Cohen, P. Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett. 502, 21–24 (2001).
  Article CAS Google Scholar
• Kailesh, G. et al. Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1 J. Biol. Chem. 278, 8118–8125 (2003).
  Article Google Scholar
• Zhang, J., Zhou, B., Zheng, C-F. & Zhang, Z-Y. A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates. J. Biol. Chem. 278, 29901–29912 (2003).
  Article CAS Google Scholar
• Robinson, F.L., Whitehurst, A.W., Raman, M. & Cobb, M.H. Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1. J. Biol. Chem. 277, 14848–14852 (2002).
  Google Scholar
• Wilsbacher, J.L., Goldsmith, E.J. & Cobb, M.H. Phosphorylation of MAP kinase by MAP/ERK involves multiple regions of MAP kinases. J. Biol. Chem. 274, 16988–16994 (1999).
  Article CAS Google Scholar
• Yang, C. & Pflugrath, J.W. Applications of anomalous scattering from S atoms for improved phasing of protein diffraction data collected at Cu K wavelength. Acta Crystallogr. D 57, 1480–1490 (2001).
  Article CAS Google Scholar
• Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
  Article CAS Google Scholar
• Brunger, A.T. et al. Crystallography & NMR system (CNS): a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998).
  Article CAS Google Scholar
• Murshudov, G.N., Vagin, A.A. & Dodson, E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240–255 (1997).
  Article CAS Google Scholar
• Collaborative Computational Project, Number 4. CCP4 Suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
• Vagin, A.A. & Teplyakov, A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30, 1022–1025 (1997).
  Article CAS Google Scholar
• Laue, T.M., Shah, B.D., Ridgeway, T.M. & Pelletier, S.L. Computer-aided interpretation of analytical sedimentation data for proteins. In Analytical Ultracentrifugation in Biochemistry and Polymer Science (eds. Harding, S.E., Rowe, A.J. & Horton, J.C.) 90–125 (The Royal Society of Chemistry, Cambridge, 1992).
  Google Scholar
• Carson, M. Ribbon models of macromolecules. J. Mol. Graphics 5, 103–106 (1987).
  Article CAS Google Scholar